 The Company received approximately 1.06 million in additional net proceeds from the sale of these shares, after deducting the underwriting discount. The Company intends to use the net proceeds from the offering for research and development activities, sales and marketing, and for general working capital purposes. Copies of the final prospectus relating to the offering may be obtained by contacting ThinkEquity, 17 State Street, 22nd Floor, New York, NY 10004, telephone 877 436-3673, email: and is available on the SECs website at 